Real-time enrollment status for this blood cancer clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT04977024 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Blood Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 240 participants |
| Active Locations | 6 sites in the US |
| Sponsor | GeoVax, Inc. |
| Last Updated on CT.gov | February 11, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT04977024 is currently active_not_recruiting participants. This clinical trial study for blood cancer is not currently accepting new participants at 6 locations across the United States. The study is sponsored by GeoVax, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04977024 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04977024 was last updated 2 weeks ago (February 11, 2026). HelloStudys verifies this status automatically.